SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : The New QLogic (ANCR) -- Ignore unavailable to you. Want to Upgrade?

To: trendmastr who wrote (19400)11/15/1998 12:24:00 PM
From: BuzzVA  Respond to of 29386
 
I agree tm. I had my parents check all three of their brokers (ML, AG Edwards, ?) to get info/opinions on ANCR and they all said (paraphrasing) "[They] wouldn't touch it with a ten foot pole." FWIW.
Hey, this is how us li'l guys/gals get our shots in. We can do the DD and take the risk these big guns can't yet. If ANCR shows the revs growth and OEM wins, we'll see them all come on board...and in a hurry! Can't wait. Keep the powder dry folks.



To: trendmastr who wrote (19400)11/15/1998 3:35:00 PM
From: George Dawson  Read Replies (2) | Respond to of 29386
 
tm:

Apparently high tech doesn't get the same respect that biotech does. I remember watching a very impressive biotech analyst on Wall Street Week five years ago. She mentioned a company called Agouron Pharmaceuticals (AGPH). I looked at it and noticed it had no cash flow and seemed highly speculative. It was $9/share and I thought it was too high priced. Three years later it was over 100 bucks a share.

George


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News